Development of RP-HPLC method for determination of amlodipine besylate, metoprolol succinate and telmisartan by integration of box-behnken design and greenness-blueness assessment tools

被引:0
作者
Prachi, Macwan [1 ]
Anand, Prajapati [1 ]
Prasha, Patel [1 ]
Devang, Tandel [1 ]
Kalpana, Patel [1 ]
机构
[1] Anand Pharm Coll, Dept Pharmaceut Qual Assurance, Anand, Gujarat, India
关键词
Amlodipine besylate; Metoprolol succinate; Telmisartan; Box-behnken design; RP-HPLC; Greenness assessment; VALIDATION; BULK;
D O I
10.1007/s00769-025-01660-y
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In this research work, a robust, Box-Behnken design-assisted reversed-phase liquid chromatography (RPLC) has been optimized for the quantification of Amlodipine Besylate, Metoprolol Succinate and Telmisartan followed by validation of method. Method is developed by utilizing Shimadzu LC-2010C HT HPLC system, autosampler injector and photodiode array detector. The separation was attained utilizing C18 (5 mu m, 250 x 4.6 mm), Phenomenex column as stationary phase. Optimized mobile phase was methanol/50 mM ammonium phosphate buffer adjusted to pH 3.5 (65:35%v/v). Detection wavelength set for estimation was 230 nm, and flow rate of mobile phase optimized was 1 ml/min. Box-Behnken design as a part of Analytical Quality by Design approach was used for optimization considering the critically influencing method attributes, flow rate (ml/min), molar concentration of buffer (mM) and buffer solution volume (ml) that resulted in optimized chromatographic conditions. The linearity exhibited a linear response within a range of 2-10 mu g/mL, 19-95 mu g/mL and 16-80 mu g/mL (correlation coefficient: 0.9988, 0.9983 and 0.9972) for Amlodipine Besylate, Metoprolol Succinate and Telmisartan, respectively. The analytical method exhibited appropriate precision and accuracy considering the RSD values as less than 2% and mean recoveries in the range of 99.99-101.00% for all three drugs. Validation was ensured in compliance with ICH Q2 (R1) in terms of method's sensitivity, accuracy, robustness and appropriate linearity for Amlodipine Besylate, Metoprolol Succinate and Telmisartan. Environmental impact evaluation of the developed method was conducted through the utilization of various software such as complex GAPI, AGREE and BAGI confirming that the optimized method was ecologic and environmentally safe. The method has been efficient in every parameter with accurate sustainability, simplicity, sensitivity and reproducibility.
引用
收藏
页数:17
相关论文
共 33 条
[1]  
[Anonymous], 2005, ICH Harmonized Tripartite Guideline Validation of Analytical Procedures: Test and Methodology Q2(R1)
[2]  
[Anonymous], 2022, ICH harmonized tripartite guideline, analytical procedure development Q14
[3]   Greenness and Whiteness Assessed Mathematically Filtered UV Spectroscopic Approaches for Quality Control of Amlodipine, Telmisartan and Metoprolol from Ternary Formulation [J].
Attimarad, Mahesh ;
Sreehari, Krishna Swaroop Duddi ;
Aldhubiab, Bandar .
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2024, 58 (04) :s1250-s1261
[4]   Design of Experimental Approach for Development of Rapid High Performance Liquid Chromatographic Process for Simultaneous Estimation of Metoprolol, Telmisartan, and Amlodipine from Formulation: Greenness and Whiteness Evaluation [J].
Attimarad, Mahesh ;
Alali, Mohammed Jassim ;
Alali, Hussain Ali ;
Alabdulmuhsin, Dana Hisham ;
Alnajdi, Aljohara Khalid ;
Venugopala, Katharigatta Narayanaswamy ;
Nair, Anroop B. .
MOLECULES, 2024, 29 (05)
[5]   Treatment of Hypertension: A Review [J].
Carey, Robert M. ;
Moran, Andrew E. ;
Whelton, Paul K. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (18) :1849-1861
[6]  
Chaudhary BR, 2020, Indo Global Journal of Pharmaceutical Sciences, V10, P06, DOI [10.35652/igjps.2020.10302, 10.35652/IGJPS.2020.10302, DOI 10.35652/IGJPS.2020.10302]
[7]  
Dadge S, 2018, Asian Journal of Research in Chemistry, V11, P755, DOI [10.5958/0974-4150.2018.00133.5, 10.5958/0974-4150.2018.00133.5, DOI 10.5958/0974-4150.2018.00133.5]
[8]  
Deore AB, 2019, Asian Journal of Pharmaceutical Research and Development, V7, P62, DOI [10.22270/ajprd.v7i6.616, 10.22270/ajprd.v7i6.616, DOI 10.22270/AJPRD.V7I6.616]
[9]  
Deore K., 2024, AFJBS, V6, P1564
[10]  
Deshmukh TB, 2018, Journal of the Chinese Advanced Materials Society, V6, P329, DOI [10.1080/22243682.2018.1425905, 10.1080/22243682.2018.1425905, DOI 10.1080/22243682.2018.1425905]